Dr. Sorror is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000- Is this information wrong?
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2008 - 2010
University of Assiut Faculty of MedicineClass of 1993
Certifications & Licensure
MT State Medical License 2022 - 2026
WA State Medical License 2005 - 2024
Clinical Trials
- Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2004 Dec 01
- Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia Start of enrollment: 2010 Mar 18
- Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203.Michelle Zhang, Megan Othus, Kerry McMillen, John Pagel, Mary-Elizabeth Percival, Harry Erba, Guillermo Garcia-Manero, Mohamed Sorror> ;Research Square. 2024 Mar 11
- 1 citationsIntensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients.Hayashi, R. J., Hayashi, R. J., De Oliveira, S. N., Matt S Zinter, Ruta Brazauskas, Joelle Strom, Stella Chen, Stephanie Bo-Subait, Akshay Sharma, Amer Beitinjaneh, Di...> ;Blood Advances. 2024 Feb 27
- What makes a pediatric or young adult patient an appropriate transplant candidate?Thakar, M., Sorror, M.> ;Hematology. American Society of Hematology. Education Program. 2023 Dec 8
- Join now to see all
Journal Articles
- Pre-Transplant Expressions of microRNAs, Comorbidities, and Post-Transplant MortalityMohamed L Sorror, Muneesh Tewari, Nature
Press Mentions
Fred Hutch at ASH: Press Briefing on CAR T-cell Therapy, CRISPR for Blood Disorders, MoreNovember 26th, 2018
Age No Longer a Barrier to Stem Cell Transplantation for Older PatientsNovember 2nd, 2011- Use of Low-Toxicity Conditioning Regimen Prior to Cell Transplantation Appears Promising for Older Adults with Blood, Bone Marrow CancersNovember 1st, 2011
Grant Support
- Impact Of Comorbidities On Outcomes Of Allogeneic TransplantationNational Heart, Lung, And Blood Institute2011–2012
- Impact Of Comorbidities On Outcomes Of Allogeneic TransplantationNational Heart, Lung, And Blood Institute2007–2008
Hospital Affiliations
Fred Hutchinson Cancer CenterSeattle, Washington
UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
